Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HSCS NASDAQ:NVNO NASDAQ:TNON NASDAQ:VBIO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSCSHeartSciences$2.04-1.4%$2.05$1.63▼$6.47$6.59M1.9633,735 shs19,167 shsNVNOenVVeno Medical$10.71-0.4%$10.87$8.67▼$196.70$7.18M1.110,856 shs8,138 shsTNONTenon Medical$0.63+0.7%$0.74$0.58▼$2.48$7.24M1.2689,157 shs39,541 shsVBIOValion Bio, Inc. Common Stock$0.65-1.8%$0.98$0.60▼$5.60$2.10M1.79115,014 shs85,287 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSCSHeartSciences-1.45%+12.71%+2.51%-25.27%-48.22%NVNOenVVeno Medical-0.40%-3.86%+2.00%-11.56%-91.18%TNONTenon Medical+0.74%-9.43%-19.47%-17.83%-40.57%VBIOValion Bio, Inc. Common Stock-1.78%-26.62%-29.89%-20.27%-84.23%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSCSHeartSciences$2.04-1.4%$2.05$1.63▼$6.47$6.59M1.9633,735 shs19,167 shsNVNOenVVeno Medical$10.71-0.4%$10.87$8.67▼$196.70$7.18M1.110,856 shs8,138 shsTNONTenon Medical$0.63+0.7%$0.74$0.58▼$2.48$7.24M1.2689,157 shs39,541 shsVBIOValion Bio, Inc. Common Stock$0.65-1.8%$0.98$0.60▼$5.60$2.10M1.79115,014 shs85,287 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSCSHeartSciences-1.45%+12.71%+2.51%-25.27%-48.22%NVNOenVVeno Medical-0.40%-3.86%+2.00%-11.56%-91.18%TNONTenon Medical+0.74%-9.43%-19.47%-17.83%-40.57%VBIOValion Bio, Inc. Common Stock-1.78%-26.62%-29.89%-20.27%-84.23%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSCSHeartSciences 2.00Hold$8.00292.16% UpsideNVNOenVVeno Medical 1.50ReduceN/AN/ATNONTenon Medical 2.00HoldN/AN/AVBIOValion Bio, Inc. Common Stock 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest VBIO, TNON, NVNO, and HSCS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2026TNONTenon Medical Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy4/20/2026TNONTenon Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/20/2026VBIOValion Bio, Inc. Common Stock Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026HSCSHeartSciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026NVNOenVVeno Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/24/2026HSCSHeartSciences Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.00 ➝ $8.00(Data available from 6/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSCSHeartSciencesN/AN/AN/AN/A$0.18 per shareN/ANVNOenVVeno MedicalN/AN/AN/AN/A$41.38 per shareN/ATNONTenon Medical$3.94M1.85N/AN/A$0.18 per share3.50VBIOValion Bio, Inc. Common Stock$780K2.65N/AN/A$6.65 per share0.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSCSHeartSciences-$8.77M-$4.94N/AN/AN/AN/A-333.50%-140.18%7/23/2026 (Estimated)NVNOenVVeno Medical-$19.47M-$25.54N/AN/AN/AN/A-66.39%-60.42%7/30/2026 (Estimated)TNONTenon Medical-$12.56M-$1.29N/AN/AN/A-270.09%-907.60%-110.17%8/12/2026 (Estimated)VBIOValion Bio, Inc. Common Stock-$8.88M-$6.68N/AN/AN/AN/A-138.10%-63.67%N/ALatest VBIO, TNON, NVNO, and HSCS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026VBIOValion Bio, Inc. Common StockN/A-$2.23N/A-$2.23N/AN/A5/12/2026Q1 2026TNONTenon Medical-$0.3050-$0.31-$0.0050-$0.31$1.30 million$1.38 million5/7/2026Q1 2026NVNOenVVeno Medical-$8.40-$5.89+$2.51-$5.89$0.50 millionN/A3/30/2026Q4 2025VBIOValion Bio, Inc. Common Stock-$408.00-$1.0310+$406.9690-$1.35$0.46 millionN/A3/19/2026Q4 2025TNONTenon Medical-$0.36-$0.22+$0.14-$0.22$1.38 million$1.48 million3/16/2026Q3 2026HSCSHeartSciences-$0.84-$0.63+$0.21-$0.63N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHSCSHeartSciencesN/AN/AN/AN/AN/ANVNOenVVeno MedicalN/AN/AN/AN/AN/ATNONTenon MedicalN/AN/AN/AN/AN/AVBIOValion Bio, Inc. Common StockN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSCSHeartSciences0.161.191.04NVNOenVVeno MedicalN/A11.8911.89TNONTenon MedicalN/A1.030.92VBIOValion Bio, Inc. Common Stock0.623.313.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSCSHeartSciences17.24%NVNOenVVeno Medical34.71%TNONTenon Medical22.74%VBIOValion Bio, Inc. Common Stock4.25%Insider OwnershipCompanyInsider OwnershipHSCSHeartSciences4.90%NVNOenVVeno Medical15.00%TNONTenon Medical0.33%VBIOValion Bio, Inc. Common Stock14.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSCSHeartSciences103.18 million3.03 millionNot OptionableNVNOenVVeno Medical30670,000568,000OptionableTNONTenon Medical811.57 million11.54 millionNot OptionableVBIOValion Bio, Inc. Common Stock103.20 million2.74 millionNot OptionableVBIO, TNON, NVNO, and HSCS HeadlinesRecent News About These CompaniesValion Bio, Inc. Common Stock (NASDAQ:VBIO) versus CVR Medical (OTCMKTS:CRRVF) Critical ContrastMay 28, 2026 | americanbankingnews.comVALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROMEMay 19, 2026 | prnewswire.comValion Bio, Inc.: Valion Bio Reports First Quarter 2026 Financial ResultsMay 15, 2026 | finanznachrichten.deValion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling workMay 14, 2026 | seekingalpha.comValion Bio Inc. (VBIO) Q1 2026 Earnings Call Prepared Remarks TranscriptMay 14, 2026 | seekingalpha.comValion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ PlatformMay 14, 2026 | prnewswire.comVALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSMay 14, 2026 | prnewswire.comValion Bio to Report First Quarter 2026 Financial Results on May 14, 2026May 11, 2026 | prnewswire.comValion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™May 6, 2026 | prnewswire.comVALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSIONMay 5, 2026 | prnewswire.comTivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple ...April 23, 2026 | finance.yahoo.comTivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream ModelApril 23, 2026 | prnewswire.comSheryle Bolton Purchases 10,000 Shares of Tivic Health Systems (NASDAQ:TIVC) StockApril 21, 2026 | insidertrades.comTivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7thApril 15, 2026 | prnewswire.comTivic Health Systems, Inc.April 3, 2026 | edition.cnn.comTivic Health Systems (NASDAQ:TIVC) Director Christina Rizopoulos Valauri Acquires 19,000 SharesApril 3, 2026 | insidertrades.comTivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of EntolimodMarch 31, 2026 | accessnewswire.comAHead to Head Analysis: Tivic Health Systems (NASDAQ:TIVC) versus American Well (NYSE:AMWL)March 29, 2026 | defenseworld.netDTivic Health Systems: Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual ConferenceMarch 27, 2026 | finanznachrichten.deTivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual ConferenceMarch 27, 2026 | accessnewswire.comANew MarketBeat Followers Over TimeMedia Sentiment Over TimeVBIO, TNON, NVNO, and HSCS Company DescriptionsHeartSciences NASDAQ:HSCS$2.04 -0.03 (-1.45%) Closing price 06/3/2026 03:59 PM EasternExtended Trading$1.97 -0.07 (-3.43%) As of 06/3/2026 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.enVVeno Medical NASDAQ:NVNO$10.71 -0.04 (-0.37%) Closing price 06/3/2026 03:59 PM EasternExtended Trading$10.68 -0.04 (-0.33%) As of 06/3/2026 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial. Tenon Medical NASDAQ:TNON$0.63 +0.00 (+0.74%) Closing price 06/3/2026 04:00 PM EasternExtended Trading$0.63 0.00 (-0.63%) As of 06/3/2026 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.Valion Bio, Inc. Common Stock NASDAQ:VBIO$0.64 -0.01 (-1.78%) As of 06/3/2026 04:00 PM EasternTivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Coke's $10B India IPO Plan Pops the Top on Hidden Value Palo Alto Networks Accelerates Growth 31% on AI Demand Motorola's $1.5B Bet to Own the Skies Microsoft Build 2026 Is Really Just One Big AI Stress Test FedEx Unboxes Billions in Post-Spinoff Value Slice of the Pie: Why Yum’s Deal Lifts QSR Urban Outfitters Stock Stalls Despite Another Strong Quarter What IBM's $10-Billion Quantum Project Means For Smaller Players Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
